These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 23695431
21. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566 [Abstract] [Full Text] [Related]
22. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy. Keruakous AR, Sadek BT, Shenouda MN, Niemierko A, Abi Raad RF, Specht M, Smith BL, Taghian AG. Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906 [Abstract] [Full Text] [Related]
23. Should breast density influence patient selection for breast-conserving surgery? Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, Brogi E, Morrow M. Ann Surg Oncol; 2013 Feb; 20(2):600-6. PubMed ID: 22941162 [Abstract] [Full Text] [Related]
24. Nationwide trends in mastectomy for early-stage breast cancer. Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. JAMA Surg; 2015 Jan; 150(1):9-16. PubMed ID: 25408966 [Abstract] [Full Text] [Related]
25. Breast cancer recurrence after mastectomy: diagnosis with mammography and US. Rissanen TJ, Mäkäräinen HP, Mattila SI, Lindholm EL, Heikkinen MI, Kiviniemi HO. Radiology; 1993 Aug; 188(2):463-7. PubMed ID: 8327698 [Abstract] [Full Text] [Related]
26. CAUSES OF DEATH IN PATIENTS WITH STAGE 0-II BREAST CANCER. Ursaru M, Jari I, Naum A, Scripcariu V, Negru D. Rev Med Chir Soc Med Nat Iasi; 2015 Aug; 119(2):374-8. PubMed ID: 26204639 [Abstract] [Full Text] [Related]
27. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Shin HC, Han W, Moon HG, Im SA, Moon WK, Park IA, Park SJ, Noh DY. Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119 [Abstract] [Full Text] [Related]
28. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy. Yilmaz MH, Esen G, Ayarcan Y, Aydoğan F, Ozgüroğlu M, Demir G, Beşe N, Mandel NM. Diagn Interv Radiol; 2007 Mar; 13(1):13-8. PubMed ID: 17354188 [Abstract] [Full Text] [Related]
30. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy. Vila J, Gandini S, Gentilini O. Breast; 2015 Jun; 24(3):175-81. PubMed ID: 25728282 [Abstract] [Full Text] [Related]
31. Imaging surveillance for the detection of ipsilateral local tumor recurrence in patients who underwent oncoplastic breast-conserving surgery with acellular dermal matrix: abbreviated MRI versus conventional mammography and ultrasonography. Kim MY, Suh YJ, An YY. World J Surg Oncol; 2021 Sep 27; 19(1):290. PubMed ID: 34579740 [Abstract] [Full Text] [Related]
32. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Park CC, Rembert J, Chew K, Moore D, Kerlikowske K. Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):75-9. PubMed ID: 18692323 [Abstract] [Full Text] [Related]
33. Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome. Gentilini O, Intra M, Gandini S, Peruzzotti G, Winnikow E, Luini A, Veronesi P, Galimberti V, Goldhirsch A, Veronesi U. J Surg Oncol; 2006 Oct 01; 94(5):375-9. PubMed ID: 16967462 [Abstract] [Full Text] [Related]
34. What Should We Know in Postoperative Surveillance Imaging After Oncoplastic Breast-Conserving Surgery with Pellet-Type Acellular Dermal Matrix? An YY, Hwang H, Suh YJ. Acad Radiol; 2023 Sep 01; 30 Suppl 2():S16-S24. PubMed ID: 37263859 [Abstract] [Full Text] [Related]
35. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P. Invest Radiol; 2003 May 01; 38(5):250-6. PubMed ID: 12750613 [Abstract] [Full Text] [Related]
36. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Nucl Med Commun; 2012 Jun 01; 33(6):591-6. PubMed ID: 22334135 [Abstract] [Full Text] [Related]
37. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS). Reyna C, Kiluk JV, Frelick A, Khakpour N, Laronga C, Lee MC. J Surg Oncol; 2015 Jun 01; 111(7):813-8. PubMed ID: 25753101 [Abstract] [Full Text] [Related]
38. Ultrasonography-guided breast-conserving surgery is superior to palpation-guided surgery for palpable breast cancer. Eggemann H, Ignatov T, Beni A, Costa SD, Ignatov A. Clin Breast Cancer; 2014 Feb 01; 14(1):40-5. PubMed ID: 24169374 [Abstract] [Full Text] [Related]
39. Feasibility of breast conserving surgery in multifocal breast cancers. Kadioğlu H, Yücel S, Yildiz S, Bozkurt S, Ersoy YE, Sağlam E, Müslümanoğlu M. Am J Surg; 2014 Sep 01; 208(3):457-64. PubMed ID: 24112680 [Abstract] [Full Text] [Related]
40. CIH-Tokyo experience with breast-conserving surgery without radiotherapy: 6.5 year follow-up results of 1462 patients. Kasumi F, Takahashi K, Nishimura S, Iijima K, Miyagi U, Tada K, Makita M, Iwase T, Oguchi M, Yamashita T, Akiyama F, Sakamoto G. Breast J; 2006 Sep 01; 12(5 Suppl 2):S181-90. PubMed ID: 16958999 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]